PSHP 2026 Residency Conference has ended

PSHP 2026 Residency Conference

arrow_back View All Dates

10:40am EDT

Oral Stepdown Therapy for Gram-Negative Bacteremia in Obesity: High-Bioavailability Agents (Fluoroquinolones, Sulfamethoxazole-Trimethoprim) Versus Low-Bioavailability Agents (Beta-Lactams) a.Pavilion Hub WESTElisa Morgan • Adrienne Michelet • Danielle Miller • Abigail Zim, PharmD

11:00am EDT

Oral Third Generation Cephalosporins versus Standard of Care for the Treatment of Penicillin-non-susceptible, Ceftriaxone-susceptible Alpha-hemolytic Streptococcal Infections a.Pavilion Hub WESTElisa Morgan • Adrienne Michelet • Danielle Miller • Joseph Lalla

11:20am EDT

Comparison of Polymerase Chain Reaction (PCR) vs. Culture-Based Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screenings on Time to Vancomycin De-escalation during Pneumonia Treatment a.Pavilion Hub WESTElisa Morgan • Adrienne Michelet • Danielle Miller • Anna Nahirnyak

2:00pm EDT

Real-World Safety and Tolerability of Contemporary Dual Beta-Lactam Regimens Initiated During Hospitalization Broad Hub EASTSeung Ha • Bonny Brownstein • Joy Cao

2:20pm EDT

Real-World Implementation of Long-Acting Injectable Antiretroviral Therapy for HIV Treatment and Pre-Exposure Prophylaxis: Adherence, Retention, And Outcomes Broad Hub EASTSeung Ha • Bonny Brownstein • Audrey Siana PharmD.

2:40pm EDT

Evaluation of Antimicrobial Therapy and Clinical Outcomes for Patients with Streptococcus pneumoniae Bacteremia or Pneumonia with and without β-lactam Allergies Broad Hub EASTSeung Ha • Bonny Brownstein • Kaylee Goodson